Hosted on MSN1d
First Drug OK'd for Chronic Rhinosinusitis With Nasal Polyps in Adolescents
The FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal ...
Zacks.com on MSN8h
Biotech Stock Roundup: GILD, NUVL Stocks Surge on Study Data, MRNA Down on Updates
It was a busy week for the biotech sector with a lot of important data readouts at the European Society for Medical Oncology ...
Monthly Prescribing Reference6d
Dupixent Approval Expanded to Include Adolescent Patients With CRSwNP
The Food and Drug Administration (FDA) has expanded the approval of Dupixent ® (dupilumab) to include add-on maintenance treatment of adolescent patients aged 12 to 17 years with inadequately ...
Dupixent® (dupilumab) Approved in the U.S. as First and Only Treatment for Adolescents with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Following Priority Review, Dupixent is now available to patients as young as 12 years with inadequately controlled CRSwNPCurrent treatment ...
Pharmabiz21d
GSK receives Japanese MHLW approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps
GSK receives Japanese MHLW approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Thursday, August 29, 2024, 09:00 Hrs [IST] GSK plc announc ...
Daily6d
Long-Term Dupilumab Therapy may provide sustained Symptom Relief among patients with CRSwN: Study
In a recent study investigators established that extended dupilumab therapy-up to three years-is highly effective in the ...
NoGarlicNoOnions1d
Nasal Scope Procedure Explained - What to Expect During a Nose Scope?
During a nasal endoscopy, the health care provider tries to look inside your nose or the opening of the sinus passage to ...